Anaplastic lymphoma kinase (ALK) positive inflammatory pseudotumor of the liver: conservative treatment and long-term follow-up.
Salakos
C
C
School of Medicine, University of Patras, Department of Pediatric Surgery, Patras, Greece. csalakos@otenet.gr
Nikolakopoulou
N M
NM
De Verney
Y
Y
Tsamandas
A C
AC
Ziambaras
T
T
Petsas
T
T
Papanastasiou
D A
DA
D000077548:Anaplastic Lymphoma Kinase; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D001706:Biopsy; D001803:Blood Transfusion / Q000379:methods*; D002648:Child; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006104:Granuloma, Plasma Cell / Q000175:diagnosis / Q000201:enzymology* / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000175:diagnosis / Q000201:enzymology* / Q000628:therapy; D008297:Male; D011505:Protein-Tyrosine Kinases / Q000097:blood*; D020794:Receptor Protein-Tyrosine Kinases; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D014408:Biomarkers, Tumor; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases